Magenta therapeutics announces executive changes

Magenta therapeutics announced the appointment of jan pinkas, ph.d., as senior vice president, translational sciences. the company also announced that mike cooke, ph.d., chief scientific officer, will leave magenta to pursue other opportunities. dr. pinkas is a seasoned scientist with deep expertise in leading drug development programs, specifically adcs. prior to joining magenta, he was head of translational research & development at immunogen, where he led nonclinical and translational research and development-related activities for all programs in discovery through late-stage clinical development. dr. pinkas earned his undergraduate degree in biology from johns hopkins university and his doctorate in molecular and cellular biology from the university of massachusetts at amherst.
DNTH Ratings Summary
DNTH Quant Ranking